StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
ResMed (RMD) PT Lowered to $215 at Wells Fargo
August 7, 2026 8:24 AM
Wells Fargo analyst Nathan Treybeck ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change